← Leaderboards
John Pulikkan
Versiti Blood Health, Inc.
$545,170
Attributed
$545,170
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$545,170 · 1
By mechanism
R01$545,170 · 1
Top collaborators
No co-investigators on record.
Most similar at Versiti Blood Health, Inc.
Same institution · by research overlap
- Michael W Deininger$12,562,286
Others in their field
Other Rising Stars on “Acute Myeloid Leukemia Cell”
- Javier Caravaca · University Of California, San Francisco$3,728,080
- Kellie Bickel · Twinstrand Biosciences, Inc.$2,555,383
- Saad J. Kenderian · Mayo Clinic Rochester$2,442,317
- Jeevisha Bajaj · University Of Rochester$2,438,184
- Bruno Di Stefano · Baylor College Of Medicine$2,398,360
- Angela Goffredo Fleischman · University Of California-Irvine$2,306,090
Research focus
Acute Myeloid Leukemia CellAdultAntileukemic AgentApoptosisArchitectureArtificial Intelligence ModelBindingCancer CellCancer TherapyCancer TypeCell Death InductionCellsCell SurvivalChromosome InversionClinically SignificantClinical TrialsCore-Binding FactorDrug ResistanceEukaryotic Initiation Factor-4gFoundationsGeneticGenome-WideHematopoiesisAcute Myelocytic Leukemia